Is Zymeworks Inc. overvalued?

Zymeworks Inc. (ZYME) — key valuation metrics and fundamentals.

No verdict

Price

$26.25

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$1.93B

Dividend yield

0.0%

Return on equity

-72.1%

Sector

Healthcare

Fair value compares ZYME's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 9 Sep 2026.

Related stocks